Remission of systemic lupus erythematosus disease activity with regulatory cytokine interleukin (IL)‐35 in Murphy Roths Large (MRL)/lpr mice

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2249|181|2|253-266

ISSN： 0009-9104

Source： CLINICAL & EXPERIMENTAL IMMUNOLOGY, Vol.181, Iss.2, 2015-08, pp. : 253-266

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Elevated serum interleukin‐35 is associated with disease activity in patients with systemic lupus erythematosus

By  

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (ELECTRONIC), Vol. 20, Iss. 12, 2017-12 ,pp. : 2154-2156

John Wiley & Sons Inc

Access to resources Recommend Favorite

Systemic 70% Deacetylated Chitin (DAC‐70) as a Treatment for MRL/lpr Murine Lupus; Reduction of Immunoglobulin Deposition in the Skin and Kidneys

By  

THE JOURNAL OF DERMATOLOGY, Vol. 24, Iss. 1, 1997-01 ,pp. : 63-65

John Wiley & Sons Inc

Access to resources Recommend Favorite

Brief Report: Interleukin‐38 Exerts Antiinflammatory Functions and Is Associated With Disease Activity in Systemic Lupus Erythematosus

By  

ARTHRITIS & RHEUMATOLOGY, Vol. 67, Iss. 12, 2015-12 ,pp. : 3219-3225

John Wiley & Sons Inc

Access to resources Recommend Favorite

Evaluation of the Japanese‐Chinese Herbal Medicine, Kampo, for the Treatment of Lupus Dermatoses in Autoimmune Prone MRL/Mp‐lpr/lpr Mice

By  

THE JOURNAL OF DERMATOLOGY, Vol. 21, Iss. 12, 1994-12 ,pp. : 935-939

John Wiley & Sons Inc

Access to resources Recommend Favorite

A longitudinal analysis of costs associated with change in disease activity in systemic lupus erythematosus

By Kan Hong  

Journal of Medical Economics, Vol. 16, Iss. 6, 2013-06 ,pp. : 793-800

Informa Healthcare

Access to resources Recommend Favorite